Answer
Dovato can be used during pregnancy if clinically needed, although data on the dual combination are absent or limited (fewer than 300 exposed outcomes), and its safety and efficacy as dual therapy have not been studied in pregnancy.
Sources for this answer
- Dovato 50 mg/300 mg film-coated tabletsViiV Healthcare UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 17Document updated
Sources checked